ARNA

Arena Pharmaceuticals, Inc. Press Releases

$4.33
*  
0.01
0.23%
Get ARNA Alerts
*Delayed - data as of Mar. 27, 2015  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By











Arena Pharmaceuticals Announces Agreement to Sell Common Stock
1/21/2015 8:45:00 AM - PR Newswire
▼-12.88 % Price Change since this news event. The Volume Ratio is 1.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals Announces Public Offering of Common Stock
1/20/2015 4:04:00 PM - PR Newswire
▼-16.09 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension
1/12/2015 8:00:00 AM - PR Newswire
▼-19.22 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials
1/9/2015 8:45:00 AM - PR Newswire
▼-27.83 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV
1/9/2015 8:00:00 AM - PR Newswire
▼-26.24 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases
1/7/2015 8:00:00 AM - PR Newswire
▲31.21 % Price Change since this news event. The Volume Ratio is 29.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/6/2015 8:00:00 AM - PR Newswire
▲23.01 % Price Change since this news event. The Volume Ratio is 0.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day